Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Leaky Scanning02:28

Leaky Scanning

5.9K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.9K
Influenza01:27

Influenza

42
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
42

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structural and functional characterization of a monoclonal antibody blocking TIGIT.

mAbs·2022
Same author

MG1141A as a Highly Potent Monoclonal Neutralizing Antibody Against SARS-CoV-2 Variants.

Frontiers in immunology·2021
Same author

Modeling and performance analysis of shuttle-based compact storage systems under parallel processing policy.

PloS one·2021
Same author

Effective Adsorption and Sensitive Detection of Cr(VI) by Chitosan/Cellulose Nanocrystals Grafted with Carbon Dots Composite Hydrogel.

Polymers·2021
Same author

CRPGCN: predicting circRNA-disease associations using graph convolutional network based on heterogeneous network.

BMC bioinformatics·2021
Same author

Update on treatment and preventive interventions against COVID-19: an overview of potential pharmacological agents and vaccines.

Molecular biomedicine·2021

Related Experiment Video

Updated: Apr 4, 2026

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
10:39

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

Published on: June 25, 2015

13.4K

M2e-Based Universal Influenza A Vaccines.

Lei Deng1,2, Ki Joon Cho3,4, Walter Fiers5,6

  • 1Inflammation Research Center, VIB, Technologiepark 927, B-9052 Ghent, Belgium. Lei.deng@dmbr.vib-ugent.be.

Vaccines
|September 8, 2015
PubMed
Summary
This summary is machine-generated.

Developing a universal influenza vaccine targeting the conserved M2e protein offers a promising strategy to overcome the limitations of current seasonal vaccines. This approach could provide broad protection against influenza A viruses, reducing the need for annual updates and enhancing pandemic preparedness.

Keywords:
influenzamatrix protein 2vaccines

More Related Videos

Quantitative Analyses of all Influenza Type A Viral Hemagglutinins and Neuraminidases using Universal Antibodies in Simple Slot Blot Assays
13:12

Quantitative Analyses of all Influenza Type A Viral Hemagglutinins and Neuraminidases using Universal Antibodies in Simple Slot Blot Assays

Published on: April 4, 2011

18.9K
Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

8.8K

Related Experiment Videos

Last Updated: Apr 4, 2026

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
10:39

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

Published on: June 25, 2015

13.4K
Quantitative Analyses of all Influenza Type A Viral Hemagglutinins and Neuraminidases using Universal Antibodies in Simple Slot Blot Assays
13:12

Quantitative Analyses of all Influenza Type A Viral Hemagglutinins and Neuraminidases using Universal Antibodies in Simple Slot Blot Assays

Published on: April 4, 2011

18.9K
Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

8.8K

Area of Science:

  • Virology
  • Immunology
  • Vaccinology

Background:

  • Current influenza vaccines require annual updates due to rapid viral evolution.
  • Existing vaccines target variable epitopes, limiting their effectiveness against drifted strains.
  • A universal influenza vaccine could provide broader, long-lasting protection.

Purpose of the Study:

  • To review the development and potential of Matrix 2 extracellular domain (M2e) as a universal influenza vaccine antigen.
  • To discuss the mechanism of action and clinical progress of M2e-based vaccines.
  • To explore future clinical implementation of M2e vaccines.

Main Methods:

  • Review of seminal and recent scientific literature on M2e as a vaccine antigen.
  • Analysis of M2e-based vaccine mechanisms and clinical trial data.
  • Forecasting potential clinical applications of M2e vaccines.

Main Results:

  • The extracellular domain of Matrix 2 (M2e) protein is a conserved epitope in influenza A viruses.
  • M2e-based vaccines have shown promise in preclinical and clinical studies.
  • Targeting conserved epitopes like M2e could lead to vaccines requiring less frequent updates.

Conclusions:

  • M2e represents a viable antigen for a universal influenza vaccine.
  • Further clinical development is needed to establish M2e vaccines as a standard preventative measure.
  • M2e vaccines hold significant potential for improving global influenza control and pandemic response.